Yep Great find Wwend. All roads are pointing to Germany.
To me if it is Bene product its further verification of final FDA approval and potentially earlier. If not then we are covered with Patents and time but competition is closing.
The ground swell is commencing and IPPS looks like it might finally be getting the recognition it deserves. Let’s hope PAR has the capability to convert the opportunity.
The Pool
research reports and media, page-3435
-
- There are more pages in this discussion • 753 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.035(12.7%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 31.0¢ | 27.5¢ | $108.9K | 371.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 17420 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |